Thomson Medical (SGX:A50) expects to swing to a loss after tax for the fiscal first half ended Dec. 31, 2024, after booking a SG$4.9 million profit in the year-ago period, according to a filing with the Singapore Exchange on Friday.
The company attributed the anticipated loss to the "poorer performance" of the Malaysian market, resulting from the termination of certain insurance contracts and increased expenses.
The company is expected to release its financial results on or before Feb. 14.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.